In a study of 53 infants, adding choroid plexus cauterization to an endoscopic third ventricle procedure improved shunt-free survival, especially as babies got older.
For infants under 12 months with hydrocephalus after myelomeningocele repair, researchers evaluated endoscopic third ventriculostomy plus bilateral choroid plexus cauterization as a primary treatment. Success was defined as staying shunt-free for 12 months along with clinical and radiological improvement.
Across age groups, the shunt-free success rate rose with age: 54% in the youngest group (<3 months), 63% in babies aged 3–6 months, and 67% in those aged 6–12 months. When treatment failed, most infants needed a ventriculoperitoneal shunt, and meningitis occurred in 15% of the cohort.
Success rose with age
In 53 infants (mean age 3.4 months), shunt-free success after ETV plus choroid plexus cauterization was 54% for those under 3 months, 63% for ages 3–6 months, and 67% for ages 6–12 months. Of 20 treatment failures, 14 required a ventriculoperitoneal shunt, and 6 were managed with repeat endoscopy for stoma closure. Meningitis was the most common complication (15%), and all infants with meningitis eventually required a ventriculoperitoneal shunt.